Selectively bred apomorphine susceptible (APO-SUS) rats display a complex behavioral phenotype remarkably similar to that of human neurodevelopmental disorders, such as schizophrenia. We recently found that the APO-SUS rats have only one or two Aph-1b gene copies (I/I and II/II rats, respectively), whereas their phenotypic counterpart has three copies (III/III). Aph-1b is a component of the c-secretase enzyme complex that is involved in multiple (neuro)developmental signaling pathways. Nevertheless, surprisingly little is known about csecretase expression during development. Here, we performed a longitudinal quantitative PCR study in embryos and the hippocampus of I/I, II/II and III/III rats, and found gene-dosage dependent differences in Aph-1b, but not Aph-1a, mRNA expression throughout pre-and postnatal development. On the basis of the developmental mRNA profiles, we assigned relative activities to the various Aph-1a and -1b gene promoters. Furthermore, in the three rat lines, we observed both tissue-specific and temporal alterations in c-secretase cleavage activity towards one of its best-known substrates, the amyloid-b precursor protein APP. We conclude that the low levels of Aph-1b mRNA and c-secretase activity observed in the I/I and II/II rats during the entire developmental period may well underlie their complex phenotype.
Introduction
Selective breeding of Wistar rats that differ in their susceptibility to the dopamine receptor agonist apomorphine has resulted in the generation of two rat lines with either a high or a low susceptibility for this drug, the so-called APO-SUS and -UNSUS lines, respectively. 1, 2 Extensive phenotypic analysis of these lines revealed for the APO-SUS rats not only a strong, stereotyped gnawing response, but in addition many features that are also found in patients suffering from developmental psychiatric illnesses, such as schizophrenia. These features include information processing deficits in the brain (measured by a reduced prepulse inhibition and latent inhibition), a hyperreactive dopaminergic pathway, an increased stress response, and a variety of behavioral, neurochemical, endocrinological and immunological features. 2 While many of the differences between the APO-SUS and -UNSUS rat lines become apparent later in life, some features have been found at earlier developmental stages. For example, APO-SUS rats display a retarded development in comparison to APO-UNSUS rats, 3 such as the development and maturation of the thymus and spleen. 4 Retarded development (e.g. low birth weight and slower gestation) is also a hallmark of schizophrenia. 5, 6 As the molecular basis of the differences between the APO-SUS and -UNSUS rats, we recently identified a gene-dosage imbalance of Aph-1b.
7 APO-SUS rats have only one or two Aph-1b gene copies, whereas APO-UNSUS rats have three in tandem gene copies, resulting in reduced Aph-1b mRNA levels in the APO-SUS rats. The Aph-1b protein is a component of g-secretase, an enzyme complex that regulates the intramembrane proteolysis of a number of type I membrane proteins, including Notch, neuregulin and the Alzheimer's disease-linked amyloid-b precursor protein APP. 8 These substrates play diverse physiological roles in multiple cell types and tissues, especially during early development. 9 The minimal molecular subunit composition of an enzymatically active g-secretase complex consists of presenilin (either PS-1 or PS-2), nicastrin (Nct), presenilin enhancer 2 (PEN-2) and the anterior pharynx defective 1 protein Aph-1, in mammals Aph-1aS, -1aL or -1b. 10 We further established that the three Aph-1b rat genotypes segregated with a number of behavioral phenotypes. 7 We now generated by crossbreeding, genetic reselection and phenotyping (susceptibility for apomorphine) three lines with one, two or three copies of the Aph-1b gene against an otherwise highly similar general genetic background (I/I, II/II and III/III lines, respectively). In this study, we performed an embryonic to adult longitudinal study on the mRNA expression levels of the three Aph-1 family members in the I/I, II/II and III/III rat lines, and analyzed the g-secretase cleavage activity towards APP at a number of developmental stages.
Materials and methods

Animals
The generation of the APO-SUS and APO-UNSUS lines from Wistar rats with a high or low susceptibility to apomorphine, respectively, has been described previously. 1 When we recently discovered the Aph-1b genotypes in the APO-SUS and -UNSUS rat lines, 7 we decided to set up a crossbreeding scheme. Four male and four female I/I rats of the APO-SUS line were crossed with four female and four male III/III rats of the APO-UNSUS line, respectively. The offspring (either I/III or III/I) was intercrossed preventing brother-sister pairing and the resulting F 2 generation was genotyped for the Aph-1b locus by PCR analysis of genomic DNAs. The rats homozygous for either one or three Aph-1b gene copies were used to generate the I/I and III/III lines, respectively; apart from the Aph-1b locus, these lines have highly similar general genetic backgrounds. The crossbred I/I rats showed a significantly higher apomorphine susceptibility than the crossbred III/III rats. For the present studies, we used I/I and III/III rats of the F 3 generation of the crossbred lines. Similarly, the II/II rat line was generated by crossbreeding II/II rats of the APO-SUS line and III/III rats of the APO-UNSUS line. The presence of a vaginal plug was used to determine embryonic day 0 (ED0). Rats were bred and reared in the Central Animal Facility of the Radboud University Nijmegen under approved animal protocols and in accordance with institutional guidelines.
Quantitative RT-PCR Quantitative RT-PCR was performed as described previously. 7 The following primers were used: Aph1b 0 -AGAGGCATACA GGGACAACACA; numbers between brackets are nucleotide positions from start ATG. All PCR products were generated over intron-exon boundaries.
PCR product analysis on a 2% agarose gel revealed a single band for each primer pair used. A control (no template) was included for each primer set. Data sets were analyzed with Sequence Detection System 1.3 software.
Western blotting
Protein extractions and immunoblottings were performed as described. 11 The polyclonal antibody C87 directed towards the most C-terminal 12 amino acids of APP was used at a dilution of 1:3000, and detected both the APP full-length protein and the C-terminal fragment of APP (APP-CTF). 7 For quantification, the signals were analyzed using the Labworks 4.0 program (UVP BioImaging systems, Cambridge, United Kingdom). Western blot analysis of Aph-1b protein expression was not successful.
Statistics
Statistical evaluation of the quantitative RT-PCR and
Western blot data was performed as described (see Supplementary Information).
Results
Aph-1 mRNA levels in developing I/I, II/II and III/III rats
Real-time quantitative RT-PCR analysis of RNA from whole embryos (prenatal) and hippocampal tissue (postnatal) revealed similar overall Aph-1b mRNA expression profiles for the I/I, II/II and III/III rats with relatively low pre-and early post-natal expression that gradually increased over time until at BPND22 a plateau was reached ( Figure 1 ). Statistical analysis of the Aph-1b mRNA levels by means of a univariate ANOVA revealed significant differences between the genotypes, as well as between the time points analyzed (see Supplementary Tables 1-3 for statistical details). Subsequent one-way ANOVA per time point and post hoc Bonferroni analysis showed that the Aph-1b mRNA levels were significantly increased in the III/III hippocampal samples compared to the II/II or I/I samples at all pre-and post-natal time points tested, with the largest differences in the pre-and early post-natal samples (up to 16-fold reduction in ED13 embryos of I/I compared to III/III rats). Furthermore, in the postnatal II/II hippocampal samples the Aph-1b mRNA levels were higher than in the I/I samples and reached significant differences from PND35 onwards (up to a two-fold increase). The mRNA expression patterns of Aph-1aL in the three rat lines were reminiscent of those of Aph-1b with significant increases from PND35 onwards. In contrast, the developmental Aph-1aS mRNA expression levels were similar at all stages tested until PND100, when a significant Bthree-fold increase was observed ( Figure 1 ). For Aph-1aL as well as Aph-1aS, statistical analyses revealed no significant differences in mRNA expression levels between the three genotypes at any pre-or post-natal time point.
g-Secretase cleavage activity in developing I/I, II/II and III/III rats Next, we were interested in the effects of the differential expression of Aph-1b mRNA in the I/I, II/II and III/III rats on g-secretase cleavage activity. One of the best-known substrates of g-secretase is the APP protein. The proteolytic processing of APP starts with shedding of its extracellular domain by a-or bsecretase, leaving a C-terminal fragment (CTF) that is subsequently cleaved by g-secretase. Western blot analysis showed similar amounts of the APP holoprotein (APP-FL) in the olfactory bulb of PND13 I/I, II/II and III/III rats, whereas the levels of the direct gsecretase substrate APP-CTF were relatively high in the I/I, moderate in the II/II, and low in the III/III rats ( Figure 2 ). An increased level of APP-CTF implies reduced g-secretase activity. Statistical analysis by means of a one-way ANOVA and post hoc Bonferroni revealed between the three genotypes a significant difference in the amounts of APP-CTF relative to APP-FL (F[2,8] = 13.5 P < 0.05), namely an B1.4-fold and an B1.8-fold higher ratio in the I/I rats relative to the II/II and III/III rats, respectively. Thus, the degree of proteolytic processing of APP by the g-secretase complex correlated with the Aph-1b gene dosage in the I/I, II/II and III/III rats.
As the Aph-1b mRNA expression levels significantly differed during development (Figure 1 ), we wondered whether the APP cleavage activity of gsecretase would also show ontogenic dynamics. For this purpose, we first determined the g-secretase cleavage activity (i.e. APP-CTF levels) in a number of tissues of I/I and III/III rats at PND13 to identify appropriate tissues for a more detailed longitudinal analysis. Western blot analysis revealed variations in APP-CTF levels between the various tissues ( Figure  2 ). An accumulation of the APP-CTF levels was observed in the olfactory bulb, testis, spinal cord and lung of I/I compared to III/III rats and the latter two tissues were used for the more detailed study. In the spinal cord, the levels of APP-FL gradually decreased over time for both I/I and III/III rats from PND9 onwards, whereas the APP-CTF levels increased. In contrast, lung tissue showed similar expression levels of the holoprotein throughout postnatal development, while the APP-CTF levels were markedly increased in both I/I and III/III rats from PND13 onwards (Figure 2 ). Statistical analysis of the APP-CTF/APP-FL ratio per time point revealed a significant increase of APP-CTF levels in the spinal cord of I/I compared to III/III rats already at PND2 and also at PND13 and 35, whereas in the lung significant accumulations were found from PND13 onwards (see also Supplementary Table 4 for statistical details). Thus, during development of the I/I, II/II and III/III rats the differential Aph-1b expression levels have spatio-temporal effects on g-secretase cleavage activity towards APP.
Discussion
The g-secretase enzyme is involved in a large variety of developmental signaling pathways. 8, [12] [13] [14] It is therefore surprising that little is known about the developmental expression patterns of PS, Nct, PEN-2 and Figure 1 Longitudinal study on Aph-1aL, -1aS and -1b mRNA expression levels in the I/I, II/II and III/III rats. Quantitative RT-PCR analysis of the mRNA levels of Aph-1b (a), Aph-1aL (b) and Aph-1aS (c) in total ED13 and ED17 embryos (left halves of the graphs) and in the hippocampus of PND0, 4, 9, 12, 22, 35, 60 and 100 rats (right halves of the graphs). The Aph-1b primer set detected all Aph-1b gene transcripts; the Aph-1aL or Aph-1aS primer sets detected the long or short transcripts, respectively. Results were normalized towards b-actin mRNA levels and are expressed as arbitrary units (AU) with the level in the PND0 III/III hippocampus set to 1 (per time point n = 3, plus s.e.m.). (a) Throughout development significant differences between the III/III and II/II rats as well as the III/III and I/I rats were observed for the Aph-1b mRNA levels (P < 0.05). From PND35 onwards, Aph-1b mRNA levels also differed significantly between the II/II and I/I rats (P < 0.05). (b, c) No significant differences between the three genotypes were observed for the Aph-1aL or -1aS mRNA levels.
Aph-1, the components of the g-secretase complex. In the present study, we examined the mRNA expression levels of the three Aph-1 family members (Aph-1b, -1aS and -1aL) and the g-secretase cleavage activity towards APP during the development of rats with one, two or three Aph-1b gene copies (I/I, II/II and III/ III rats, respectively). Relatively low levels of Aph-1b mRNA were detected during the pre-and early postnatal developmental stages, whereas from PND35 onwards we found increased levels that remained high during further development. This developmental Aph-1b mRNA expression profile thus suggests that in the rat the demand for Aph-1b is higher postnatally than during early development. The availability of the three Aph-1b mRNA expression profiles together with the knowledge of the genetic make-up of the Aph-1b loci in the I/I, II/II and III/III rat lines allows us to speculate about the developmental activity of the various Aph-1b gene promoters; the different sets of Aph-1b genes and gene promoters in the three rat lines are schematically depicted in Figure 3 . Despite the extra gene copy in the II/II rats, the Aph-1b mRNA expression levels were not different during early development of the I/I and II/ II rats, indicating that pre-natally either the Aph-1b gene promoter displays a relatively low activity or the Aph-1b 0 /b hybrid gene promoter has a relative high activity. Conversely, in the III/III rats we found higher Aph-1b mRNA expression levels than one would expect on the basis of three gene copies and the promoter of the Aph-1b/-1b 0 hybrid gene thus appears to display a relatively high activity throughout Figure 2 Ontogenic analysis of g-secretase cleavage activity towards APP in the I/I, II/II and III/III rats. (a) APP processing by g-secretase is dependent on the number of Aph-1b gene copies. Western blot analysis of the levels of the APP holoprotein (APP-FL) and C-terminal fragment (APP-CTF) was performed in the olfactory bulb of I/I (1), II/II (2) and III/III (3) rats at PND13. Quantification of the APP-CTF relative to the APP-FL levels revealed significant differences between the I/I and II/II, and between the I/I and III/III rats (*P < 0.05; **P < 0.02; n = 3, with the three rats from different nests, plus SEM). (b) Western blot analysis of the APP-CTF levels in a number of tissues of PND13 I/I (1) and III/III (3) rats. Tissues analyzed were olfactory bulb (olf), pons/medulla (p/m), hippocampus (hip), spinal cord (spc), cortex (ctx), (hypo)thalamus (tha), cerebellum (cer), lung (lng), liver (liv), spleen (spl), muscle (msc), testis (tes), pancreas (pan) and tongue (tng). The additional product observed in cortex and (hypo)thalamus corresponds to the b-secretase cleavage product CTFb (C99). (c, d) Western blot analysis of the levels of APP-FL and -CTF in the spinal cord (c) and lung (d) of I/I (1) and III/III (3) rats at PND2, 9, 13, 35 and 60. Significantly elevated APP-CTF/-FL ratios in I/I compared to III/III rats were found in the spinal cord at PND2, 13 and 35 and in the lung from PND13 onwards. (*P < 0.05; **P < 0.02; n = 3, with the three rats per genotype from different nests, plus s.e.m.).
development. The observed Aph-1b mRNA expression levels are therefore not always in full accordance with the number of Aph-1b gene copies.
Neither pre-nor post-natally the levels of Aph-1aS and -1aL mRNA differed between the three rat lines, indicating that these paralogs did not compensate for the altered Aph-1b mRNA levels. This is in line with the results of recent RNA interference and knockout studies on the Aph-1 family members in the mouse showing that the expression levels of the other gsecretase components were affected only when Aph1a expression was silenced and not with abolished Aph-1b expression. [15] [16] [17] Similar to the results obtained with reduced Aph-1a expression, knockdown or knockout of either of the g-secretase components PS1, Nct or PEN-2 in the mouse led to affected levels of most of the nonsilenced g-secretase subunits. [18] [19] [20] [21] [22] [23] [24] In contrast, ablation of mouse PS2 expression had little effect on the expression levels of the other g-secretase components, 20, 24, 25 comparable to what we have observed in the I/I, II/II and III/III rat lines concerning the effect of reduced Aph-1b expression. 7 These findings suggest that PS2 and Aph-1b are somehow related.
The reduced ontogenic Aph-1b mRNA levels observed in the hippocampus may well underlie the large differences in stress susceptibility of the rats with one, two or three Aph-1b gene copies, 26 as the hippocampus is known to modulate the stress axis. 27, 28 In addition, the marked hippocampal differences may be related to the dopaminergic hyperreactivity of the rats, since one of the most important projections of the hippocampus runs to the ventral striatum. 29 In psychiatric disorders, such as schizophrenia, stress susceptibility and dopaminergic hyper-reactivity have also been observed. 30, 31 According to the developmental hypothesis of schizophrenia, the pathophysiology and etiology of the disorder are related to an affected development or maturation of the brain. Epidemiological studies have provided a solid basis for this hypothesis, for example during early life schizophrenic individuals have shown a retarded motor and cognitive development. [32] [33] [34] Furthermore, disturbances in the cytoarchitecture of the hippocampal formation 35 and entorhinal cortex 36 can only be adequately explained by aberrant brain development. Unfortunately, schizophrenia has an adult onset and it has turned out to be difficult to elucidate its molecular basis. 37 Perhaps the results of our longitudinal developmental study on the I/I, II/II and III/III rat lines may help in the understanding of the molecular background of such neurodevelopmental disorders.
We have found that in the three rat lines the Aph-1b mRNA expression levels correlated with the degree of APP processing by g-secretase. Similarly, complete silencing of the expression of PS1, Nct, PEN-2 or Aph1a in the mouse resulted in reduced g-secretase activity (also indicated by elevated APP-CTF levels). 16, 21, 22, 24, 38, 39 Conversely, preventing mouse PS2 or Aph-1b expression did not affect or only slightly decreased g-secretase activity, respectively, and gave only a mild phenotype, whereas removal of PS1, Nct or Aph-1a is lethal. 16, 25 We, therefore, hypothesize that the functioning of the PS2-and Aph-1b-containing g-secretase complex is different from that of the complexes with other subunit compositions.
The reduction in APP processing that we observed may be related to the hyperactive behavior displayed by rats with one or two Aph-1b gene copies. 7 Interestingly, in mice the reverse situation, namely overexpressed APP (or APP-CTF), results in general hypoactive behavior. 40, 41 We further found that the effects on g-secretase activity were tissue specific. In general, in a tissue with a high level of Aph-1b mRNA compared to the Aph-1a mRNA level (a high Aph-1b/-1a mRNA ratio) relatively large differences in the APP-CTF levels were found between the I/I and III/III rats. In the hippocampus, a tissue with a relatively low Aph-1b/-1a ratio, 26 we did not observe significant differences in g-secretase cleavage activity between the three rat lines, while large alterations in hippocampal Aph-1b mRNA levels were detected (Beightfold at PND13). It thus appears that a reduced Aph-1b expression causes a more severe effect on g-secretase activity in tissues with a high Aph-1b/-1a ratio than in tissues with a low ratio. Furthermore, sufficient amounts of the direct g-secretase substrate APP-CTF had to be present in a tissue to allow detection of any significant difference in g-secretase cleavage activity. For instance, the lung has a high Aph-1b/-1a ratio, but we did not observe an affected g-secretase activity in early post-natal lung, presumably due to the low levels of APP-CTF in this tissue. -1b) , the II/II rats contain the Aph-1b 0 and Aph-1b genes, and the III/III rats harbor, besides the Aph-1b 0 and Aph-1b genes, an additional Aph-1b/-1b 0 hybrid gene. 7 The activities of the various promoters, as deduced from the developmental mRNA expression profiles (Figure 1 The g-secretase complex is able to cleave an evergrowing list of now at least 15 substrates and it is likely that in the I/I rats the effect of the reduced Aph1b mRNA expression was not restricted to the decreases in APP cleavage, but that the cleavages of other (developmentally important) g-secretase substrates, like Notch, neuregulin, ErbB4 and N-cadherin, were also affected. Such a broad ontogenic effect presumably resulted in not only retarded development, 3, 4 but also in the complex phenotype of the SUS rats in adulthood. 2, 7 In conclusion, a subtle ontogenic imbalance in the expression of a single g-secretase component causes spatio-temporal differences in g-secretase enzymatic activity. As g-secretase complexes with different subunit compositions are not functionally redundant and each complex is involved in the preferential cleavage of a subset of g-secretase substrates, 17 ,42 a complex (neuro)developmental phenotype may arise in an organism with altered expression of a gsecretase component. Thus, affecting the ontogenic expression of a single developmentally important protein may ultimately result in a complex phenotype later in life.
